Top

Double Chin Treatment

At last, injectable fat-burning treatments are FDA-approved in the U.S. after the concept has been acceptable in European and Asian countries for over a decade!  Kybella is an injection solution that disrupts the fat cell membrane causing its destruction. The fat cell releases its fatty contents and the body metabolizes it as its normal process.  

In addition to the option of injection treatments with Kybella for fat destruction, is the non-surgical treatment with TruSculpting. It  is a device that uses heat and radiofrequency to permanently destroy fat cells and tighten the affected area at the same time.

At Aestheticare MedSpa, either treatment or a combination of treatments might be suggested to obtain the best outcome for your needs.


ARE YOU A CANDIDATE FOR DOUBLE CHIN TREATMENTS?

When submental chin fat is resistant to weight management in spite of healthy lifestyles and fitness, and then targeting the chin for contouring with Kybella or TruSculpting can be the perfect  solution when skin laxity is not excessive.


THE BENEFITS OF  TREATMENTS FOR DOUBLE CHINS

TruSculpting and Kybella can be an ideal combination treatment plan for women and men alike who are in good health, have unwanted subcutaneous fat beneath the chin and have good skin tone.


WHAT TO EXPECT DURING TREATMENTS FOR DOUBLE CHINS

Most people are thrilled with the ease of these treatments and the minimal amount of discomfort during and after the sessions. Some redness and swelling may occur following treatments that may last 24-72 hours, occasionally longer with Kybella treatments . No work loss or social down-time is needed.


RECOVERY

Most commonly, some bruising and swelling will occur with the injection treatments and some numbness remains until the swelling subsides.


RESULTS

Some results will show within the first 2-4 weeks following treatment but results will continue to improve for up to 8-12 weeks following each session.

Have a Question?

  • This field is for validation purposes and should be left unchanged.